XORTX Therapeutics Inc (XRTX)
1.32
+0.02
(+1.54%)
USD |
NASDAQ |
Nov 14, 16:00
1.35
+0.03
(+2.27%)
After-Hours: 20:00
XORTX Therapeutics Total Liabilities (Quarterly): 2.095M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.095M |
| March 31, 2024 | 3.560M |
| December 31, 2023 | 0.8259M |
| September 30, 2023 | 0.5538M |
| June 30, 2023 | 0.4033M |
| March 31, 2023 | 0.5998M |
| December 31, 2022 | 5.377M |
| September 30, 2022 | 3.111M |
| June 30, 2022 | 2.950M |
| March 31, 2022 | 4.038M |
| December 31, 2021 | 4.179M |
| September 30, 2021 | 9.464M |
| June 30, 2021 | 3.237M |
| March 31, 2021 | 3.784M |
| December 31, 2020 | 0.811M |
| September 30, 2020 | 0.743M |
| June 30, 2020 | 0.6376M |
| March 31, 2020 | 0.825M |
| December 31, 2019 | 0.995M |
| September 30, 2019 | 0.8891M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.8122M |
| March 31, 2019 | 0.7234M |
| December 31, 2018 | 0.6929M |
| September 30, 2018 | 0.694M |
| June 30, 2018 | 0.6301M |
| March 31, 2018 | 0.6364M |
| December 31, 2017 | 0.9107M |
| November 30, 2017 | 0.0062M |
| September 30, 2017 | 0.6889M |
| August 31, 2017 | 0.0056M |
| May 31, 2017 | 0.0067M |
| February 28, 2017 | 0.0103M |
| November 30, 2016 | 0.0069M |
| August 31, 2016 | 0.0513M |
| May 31, 2016 | 0.0162M |
| February 29, 2016 | 0.0062M |
| November 30, 2015 | 0.0063M |
| August 31, 2015 | 0.0999M |
| May 31, 2015 | 0.0694M |
| February 28, 2015 | 0.0481M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.4033M
Minimum
Jun 2023
9.464M
Maximum
Sep 2021
2.536M
Average
2.095M
Median
Jun 2024
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 161.36M |
| Edesa Biotech Inc | 2.361M |
| Lexaria Bioscience Corp | 0.2714M |
| Xenon Pharmaceuticals Inc | 39.96M |
| ESSA Pharma Inc | 3.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.799M |
| Shareholders Equity (Quarterly) | 2.705M |